Cargando…

An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is an enigmatic condition characterized by exacerbation of symptoms after exertion (post-exertional malaise or “PEM”), and by fatigue whose severity and associated requirement for rest are excessive and disproportionate to the fatigue-induc...

Descripción completa

Detalles Bibliográficos
Autores principales: Missailidis, Daniel, Annesley, Sarah J., Allan, Claire Y., Sanislav, Oana, Lidbury, Brett A., Lewis, Donald P., Fisher, Paul R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036826/
https://www.ncbi.nlm.nih.gov/pubmed/32041178
http://dx.doi.org/10.3390/ijms21031074
_version_ 1783500283981070336
author Missailidis, Daniel
Annesley, Sarah J.
Allan, Claire Y.
Sanislav, Oana
Lidbury, Brett A.
Lewis, Donald P.
Fisher, Paul R.
author_facet Missailidis, Daniel
Annesley, Sarah J.
Allan, Claire Y.
Sanislav, Oana
Lidbury, Brett A.
Lewis, Donald P.
Fisher, Paul R.
author_sort Missailidis, Daniel
collection PubMed
description Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is an enigmatic condition characterized by exacerbation of symptoms after exertion (post-exertional malaise or “PEM”), and by fatigue whose severity and associated requirement for rest are excessive and disproportionate to the fatigue-inducing activity. There is no definitive molecular marker or known underlying pathological mechanism for the condition. Increasing evidence for aberrant energy metabolism suggests a role for mitochondrial dysfunction in ME/CFS. Our objective was therefore to measure mitochondrial function and cellular stress sensing in actively metabolizing patient blood cells. We immortalized lymphoblasts isolated from 51 ME/CFS patients diagnosed according to the Canadian Consensus Criteria and an age- and gender-matched control group. Parameters of mitochondrial function and energy stress sensing were assessed by Seahorse extracellular flux analysis, proteomics, and an array of additional biochemical assays. As a proportion of the basal oxygen consumption rate (OCR), the rate of ATP synthesis by Complex V was significantly reduced in ME/CFS lymphoblasts, while significant elevations were observed in Complex I OCR, maximum OCR, spare respiratory capacity, nonmitochondrial OCR and “proton leak” as a proportion of the basal OCR. This was accompanied by a reduction of mitochondrial membrane potential, chronically hyperactivated TOR Complex I stress signaling and upregulated expression of mitochondrial respiratory complexes, fatty acid transporters, and enzymes of the β-oxidation and TCA cycles. By contrast, mitochondrial mass and genome copy number, as well as glycolytic rates and steady state ATP levels were unchanged. Our results suggest a model in which ME/CFS lymphoblasts have a Complex V defect accompanied by compensatory upregulation of their respiratory capacity that includes the mitochondrial respiratory complexes, membrane transporters and enzymes involved in fatty acid β-oxidation. This homeostatically returns ATP synthesis and steady state levels to “normal” in the resting cells, but may leave them unable to adequately respond to acute increases in energy demand as the relevant homeostatic pathways are already activated.
format Online
Article
Text
id pubmed-7036826
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70368262020-03-11 An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients Missailidis, Daniel Annesley, Sarah J. Allan, Claire Y. Sanislav, Oana Lidbury, Brett A. Lewis, Donald P. Fisher, Paul R. Int J Mol Sci Article Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is an enigmatic condition characterized by exacerbation of symptoms after exertion (post-exertional malaise or “PEM”), and by fatigue whose severity and associated requirement for rest are excessive and disproportionate to the fatigue-inducing activity. There is no definitive molecular marker or known underlying pathological mechanism for the condition. Increasing evidence for aberrant energy metabolism suggests a role for mitochondrial dysfunction in ME/CFS. Our objective was therefore to measure mitochondrial function and cellular stress sensing in actively metabolizing patient blood cells. We immortalized lymphoblasts isolated from 51 ME/CFS patients diagnosed according to the Canadian Consensus Criteria and an age- and gender-matched control group. Parameters of mitochondrial function and energy stress sensing were assessed by Seahorse extracellular flux analysis, proteomics, and an array of additional biochemical assays. As a proportion of the basal oxygen consumption rate (OCR), the rate of ATP synthesis by Complex V was significantly reduced in ME/CFS lymphoblasts, while significant elevations were observed in Complex I OCR, maximum OCR, spare respiratory capacity, nonmitochondrial OCR and “proton leak” as a proportion of the basal OCR. This was accompanied by a reduction of mitochondrial membrane potential, chronically hyperactivated TOR Complex I stress signaling and upregulated expression of mitochondrial respiratory complexes, fatty acid transporters, and enzymes of the β-oxidation and TCA cycles. By contrast, mitochondrial mass and genome copy number, as well as glycolytic rates and steady state ATP levels were unchanged. Our results suggest a model in which ME/CFS lymphoblasts have a Complex V defect accompanied by compensatory upregulation of their respiratory capacity that includes the mitochondrial respiratory complexes, membrane transporters and enzymes involved in fatty acid β-oxidation. This homeostatically returns ATP synthesis and steady state levels to “normal” in the resting cells, but may leave them unable to adequately respond to acute increases in energy demand as the relevant homeostatic pathways are already activated. MDPI 2020-02-06 /pmc/articles/PMC7036826/ /pubmed/32041178 http://dx.doi.org/10.3390/ijms21031074 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Missailidis, Daniel
Annesley, Sarah J.
Allan, Claire Y.
Sanislav, Oana
Lidbury, Brett A.
Lewis, Donald P.
Fisher, Paul R.
An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients
title An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients
title_full An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients
title_fullStr An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients
title_full_unstemmed An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients
title_short An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients
title_sort isolated complex v inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from me/cfs patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036826/
https://www.ncbi.nlm.nih.gov/pubmed/32041178
http://dx.doi.org/10.3390/ijms21031074
work_keys_str_mv AT missailidisdaniel anisolatedcomplexvinefficiencyanddysregulatedmitochondrialfunctioninimmortalizedlymphocytesfrommecfspatients
AT annesleysarahj anisolatedcomplexvinefficiencyanddysregulatedmitochondrialfunctioninimmortalizedlymphocytesfrommecfspatients
AT allanclairey anisolatedcomplexvinefficiencyanddysregulatedmitochondrialfunctioninimmortalizedlymphocytesfrommecfspatients
AT sanislavoana anisolatedcomplexvinefficiencyanddysregulatedmitochondrialfunctioninimmortalizedlymphocytesfrommecfspatients
AT lidburybretta anisolatedcomplexvinefficiencyanddysregulatedmitochondrialfunctioninimmortalizedlymphocytesfrommecfspatients
AT lewisdonaldp anisolatedcomplexvinefficiencyanddysregulatedmitochondrialfunctioninimmortalizedlymphocytesfrommecfspatients
AT fisherpaulr anisolatedcomplexvinefficiencyanddysregulatedmitochondrialfunctioninimmortalizedlymphocytesfrommecfspatients
AT missailidisdaniel isolatedcomplexvinefficiencyanddysregulatedmitochondrialfunctioninimmortalizedlymphocytesfrommecfspatients
AT annesleysarahj isolatedcomplexvinefficiencyanddysregulatedmitochondrialfunctioninimmortalizedlymphocytesfrommecfspatients
AT allanclairey isolatedcomplexvinefficiencyanddysregulatedmitochondrialfunctioninimmortalizedlymphocytesfrommecfspatients
AT sanislavoana isolatedcomplexvinefficiencyanddysregulatedmitochondrialfunctioninimmortalizedlymphocytesfrommecfspatients
AT lidburybretta isolatedcomplexvinefficiencyanddysregulatedmitochondrialfunctioninimmortalizedlymphocytesfrommecfspatients
AT lewisdonaldp isolatedcomplexvinefficiencyanddysregulatedmitochondrialfunctioninimmortalizedlymphocytesfrommecfspatients
AT fisherpaulr isolatedcomplexvinefficiencyanddysregulatedmitochondrialfunctioninimmortalizedlymphocytesfrommecfspatients